The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Intrahepatic Cholestasis of Pregnancy (Advanced Management)

A pregnancy-specific liver disorder causing severe itching and elevated bile acids requiring close fetal surveillance

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Kadın Hastalıkları ve Doğum department. Book Appointment →

What is Intrahepatic Cholestasis of Pregnancy (Advanced Management)?

ICP is a hormonally-driven cholestatic liver disorder unique to pregnancy.

Pathophysiology involves estrogen-induced impaired hepatocellular bile acid transport (BSEP, MRP2 dysfunction).

Diagnosis requires pruritus (often palms/soles, worse at night) plus elevated serum total bile acids ≥ 10 µmol/L (some guidelines use 19 µmol/L).

Severity: mild (10-39 µmol/L), moderate (40-99), severe (≥ 100) - severe form carries highest fetal risk.

Resolves rapidly within days to weeks postpartum but recurs in 60-70 percent of subsequent pregnancies.

Multidisciplinary care involving obstetrician, hepatologist, and maternal-fetal medicine specialist.

Symptoms

Generalized pruritus, often starting on palms and soles, worse at night.
Absence of primary skin rash (excoriations only).
Sleep disturbance and emotional distress from itching.
Mild jaundice in 10-15 percent (rare; suggests severity).
Right upper quadrant discomfort, anorexia, malaise.
Steatorrhea or pale stools (vitamin K malabsorption risk).

Risk Factors

Personal or family history of ICP (genetic predisposition - ABCB4, ABCB11 mutations).
Multiple gestation (twins, triplets) - 5-fold higher risk.
Hepatitis C infection.
Pre-existing cholestatic liver disease.
Advanced maternal age, IVF pregnancies.
South American (Chilean), South Asian, and Scandinavian ethnicity.

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • New-onset itching in second/third trimester, especially palms and soles.
  • Itching that disrupts sleep or affects daily activities.
  • Jaundice, dark urine, pale stools, or right upper quadrant pain.
  • Decreased fetal movement.
  • Persistent severe pruritus despite topical management.
  • Postpartum follow-up to confirm resolution and discuss recurrence risk.

Treatment Methods

01
Ursodeoxycholic acid (UDCA) 10-15 mg/kg/day - first-line; reduces pruritus and bile acid levels.
02
Antihistamines (chlorpheniramine) and topical emollients for symptomatic relief.
03
Vitamin K supplementation if PT prolonged or severe disease.
04
Weekly monitoring of serum bile acids and liver enzymes.
05
Fetal surveillance with twice-weekly NST and amniotic fluid index from 32 weeks.
06
Delivery timing based on bile acid levels: ≥ 100 µmol/L deliver by 36 weeks; 40-99 by 37-38 weeks; < 40 by 39 weeks.
07
Postpartum: discontinue UDCA after symptom resolution; verify normalization of liver enzymes within 4-6 weeks.
08
Counseling regarding 60-70 percent recurrence risk and avoidance of estrogen-containing contraception.

Which Department to Visit?

You can visit our Kadın Hastalıkları ve Doğum department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Kadın Hastalıkları ve Doğum Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Regular Gynecological Check-up

Kadın Hastalıkları ve Doğum

Regular gynecological check-ups enable early diagnosis of many women's diseases and increase treatment success. It is recommended that every sexually active woman or woman over 21 see a gynecologist at least once a year.

Cervical Cancer

Kadın Hastalıkları ve Doğum

Cervical cancer develops from uncontrolled growth of cells in the cervix and is among the most common women's cancers worldwide. Precancerous lesions can be recognized with regular Pap smear and HPV testing.

HPV and Vaccination

Kadın Hastalıkları ve Doğum

HPV is a common virus transmitted sexually that can lead to certain types of cancer. Vaccination provides over 90% protection against high-risk HPV strains.

Ovarian Cyst

Kadın Hastalıkları ve Doğum

Ovarian cysts are fluid-filled sacs that form in or on the ovarian tissue. Most are asymptomatic and disappear spontaneously; however, large or complex cysts can cause pain and complications.

Endometriosis

Kadın Hastalıkları ve Doğum

Endometriosis affects about 10% of women of reproductive age, causing cyclic pelvic pain, dysmenorrhea, dyspareunia, and infertility; combined medical and laparoscopic treatment improves quality of life.

Uterine Fibroids

Kadın Hastalıkları ve Doğum

Uterine fibroids are benign tumors developing from the uterine muscle layer. They affect 20-50% of women of reproductive age; most are asymptomatic, but can cause bleeding and pain.

Polycystic Ovary Syndrome (PCOS)

Kadın Hastalıkları ve Doğum

PCOS is the most common endocrine disease affecting approximately 10% of women of reproductive age, characterized by androgen excess, ovulation disorder, and polycystic ovarian appearance.

Menopause

Kadın Hastalıkları ve Doğum

Menopause is the life stage defined by not having a period for 12 consecutive months and the natural cessation of ovarian function. The average age is 51, but it can vary between 45-55 years.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.